We invest in companies building the infrastructure of modern healthcare - AI-enabled, software-driven, and scalable across complex healthcare systems. Our portfolio reflects a focused strategy: Backing businesses that improve clinical outcomes, operational efficiency, and access to care.
Scaling category-leading healthcare technology
businesses and creating lasting impact.
Verifarma provides integrated software solutions for the pharmaceutical and life sciences industry, spanning serialization and traceability, quality management (eQMS), regulatory affairs, and pharmacovigilance. Its platform enables end-to-end visibility and compliance across the supply chain, helping companies meet global regulatory requirements and ensure the safety and authenticity of medicines. By integrating data, compliance workflows, and traceability systems into a unified platform, Verifarma enables more efficient, transparent, and scalable operations - aligned with MTIP’s focus on software-driven infrastructure in highly regulated healthcare markets.
Dossier offers cloud-based software for healthcare workforce competency and compliance management. Its platform enables healthcare providers to track, validate, and manage staff skills, ensuring workforce readiness while reducing administrative burden and supporting regulatory compliance. As a mission-critical, software-driven solution embedded in healthcare operations, Dossier reflects MTIP’s focus on scalable platforms that improve efficiency and resilience in healthcare systems.
Hexarad delivers tech-enabled radiology services that streamline imaging workflows and reporting. Combining a proprietary platform with a distributed network of radiologists, it integrates across clinical systems to manage the end-to-end radiology process, including scan allocation, reporting, and data flow, helping departments handle increasing imaging demand more efficiently. By combining workflow automation with data-driven insights and AI capabilities, Hexarad helps radiology teams optimize operations, reduce diagnostic delays, and improve resource utilization - aligned with MTIP’s focus on software- and AI-enabled services that increase efficiency in radiology departments.
Oviva delivers digital, data-driven care for patients with chronic conditions such as obesity and diabetes. Its platform combines clinical expertise with technology-enabled care pathways to improve outcomes at scale while reducing the burden on healthcare systems. By integrating data, behavioral science, digital tools, and AI-driven insights into treatment delivery, Oviva enables more efficient, personalized care - aligned with MTIP’s focus on scalable, software-driven healthcare models.
Trialbee provides software and data-driven solutions that improve patient recruitment and engagement in clinical trials. Its platform connects sponsors, sites, and patients, enabling faster enrollment, better retention, and more efficient trial execution. By leveraging data and AI to optimize patient matching and outreach, Trialbee addresses a critical bottleneck in drug development - fitting MTIP’s strategy of backing technology that enhances efficiency across the healthcare value chain.
Intelligencia AI enables AI-powered decision-making in drug development. Its platform analyzes clinical and scientific data to predict the probability of success of drug candidates, helping pharmaceutical and biotech companies prioritize assets and reduce development risk. By combining machine learning with large-scale data integration, Intelligencia AI delivers faster, more informed R&D decisions, improving capital allocation and increasing the likelihood of successful outcomes - aligned with MTIP’s focus on data-driven solutions that enhance efficiency in pharmaceutical R&D.
Axonius is an asset intelligence platform that integrates data across IT environments to deliver comprehensive visibility and actionable insights, enabling organizations to better manage risk, improve efficiency, and optimize resource utilization. In July 2025, Axonius acquired MTIP portfolio company Cynerio, a cybersecurity platform purpose-built for healthcare. Cynerio enables hospitals and health systems to secure connected medical devices and clinical networks through real-time visibility, risk detection, and automated protection - closely aligned with MTIP’s focus on software-driven healthcare solutions.
Mediktor brings AI-powered symptom assessment and digital triage to healthcare, guiding patients to the appropriate level of care. Its platform analyzes patient-reported symptoms using natural language processing and clinical algorithms to provide pre-diagnostic insights and care navigation. By integrating AI-driven triage into healthcare workflows, Mediktor improves patient access, reduces unnecessary visits, and optimizes resource utilization - aligned with MTIP’s focus on scalable, data-driven solutions that enhance operational efficiency in healthcare delivery.
LynxCare offers an AI-powered clinical data platform that mines structured and unstructured health data from hospital information systems with high accuracy and scalability. Its platform uses natural language processing to unlock the value of clinical data and make it accessible for hospitals and pharmaceutical companies. By transforming real-world data into validated real-world evidence, LynxCare supports clinical research and data-driven decision-making - aligned with MTIP’s focus on data-driven solutions that enhance efficiency in pharmaceutical development.
Coramaze focuses on developing a minimally invasive transcatheter system for the treatment of tricuspid regurgitation, a severe heart valve condition with limited therapeutic options. Its Tripair™ technology is designed to simplify valve repair procedures, aimed at safer and more accessible treatment across a broader patient population. By combining medical device innovation with a simplified procedural approach, Coramaze supports more accessible and effective treatment of structural heart disease.
Caresyntax develops a surgical intelligence platform that integrates and analyses data from the operating room to improve clinical and operational performance. Its software connects video, device, and clinical data to deliver actionable insights across surgical workflows. By leveraging data and AI-driven insights, Caresyntax enables safer, more efficient surgeries, improves patient outcomes, and optimizes resource utilization - aligned with MTIP’s focus on scalable, data-driven healthcare solutions.
Koa Health delivered digital, evidence-based mental healthcare solutions spanning prevention, early intervention, and clinical treatment. Its platform combined clinical expertise with technology-enabled care pathways to provide personalized mental health support at scale. By integrating data, behavioral science, and AI-driven insights into a unified platform, Koa Health enabled more accessible, efficient, and scalable mental healthcare - aligned with MTIP’s focus on software-driven solutions that deliver better care to patients.
Nitinotes develops minimally invasive surgical devices for bariatric procedures, enabling physicians to perform incisionless sleeve gastroplasty using endoscopic techniques. Its technology allows for effective weight-loss treatment without the need for traditional surgery, reducing procedural risk and recovery time while improving patient outcomes. By combining medical device design with minimally invasive approaches, Nitinotes enables safer and more efficient obesity treatment.
Quanta offers a compact, cartridge-based hemodialysis system designed for use across hospitals, clinics, and home settings. Its solution simplifies dialysis delivery by eliminating the need for complex disinfection processes, reducing treatment time, and enabling flexible use across care settings - helping improve patient outcomes and access to care. By combining medical device innovation with a user-friendly and scalable design, Quanta supports more efficient and patient-centric dialysis care across the continuum.
Lumeon developed a care orchestration platform that automates and coordinates clinical workflows across healthcare organizations. Its software integrated with existing systems to manage end-to-end patient pathways, reducing manual tasks and ensuring consistent, data-driven care delivery. By combining workflow automation with real-time data and clinical intelligence, Lumeon helped healthcare providers streamline operations, improve care coordination, and increase efficiency - supporting MTIP’s investment strategy in scalable software solutions that modernize healthcare operations.
TytoCare provides a telehealth solution that combines a handheld medical examination device with a digital platform, enabling clinicians to perform remote physical exams and diagnose patients from home. Its system captures clinical-grade data - including heart, lung, ear, throat, and skin assessments - and integrates with telehealth workflows to support accurate and timely care delivery. By combining connected medical devices with virtual care capabilities, TytoCare supports more accessible, efficient, and patient-centric healthcare delivery - aligned with MTIP’s focus on AI-enabled solutions that expand access and improve care.
Blueprint Genetics is a genetic testing company focused on inherited diseases. Its platform combines clinical-grade sequencing with advanced variant interpretation to enable accurate diagnosis and more informed treatment decisions. In 2020, Blueprint Genetics was acquired by Quest Diagnostics, where its capabilities continue to support the expansion of genetic testing and diagnostics services, improving access to high-quality insights in rare diseases.
Apricity brought digital-first fertility care, combining clinical expertise with technology-enabled treatment pathways to support patients throughout the fertility journey. As a virtual fertility clinic, its platform reduced the need for in-person visits while providing personalized care through a seamless, app-based experience. By integrating data and digital tools into care delivery, Apricity improved patient experience, increased the likelihood of successful outcomes, and expanded access to fertility treatment -aligned with MTIP’s focus on digital solutions that deliver better care to patients.
Reactive Robotics offers robotic assistance systems for the early mobilization of critically ill patients in intensive care settings. Its technology supports healthcare teams in safely mobilizing patients at an early stage, combining verticalization and robot-assisted movement to improve rehabilitation outcomes and reduce the burden on caregivers. By combining medical robotics with clinical workflow integration, Reactive Robotics supports earlier mobilization, improved patient recovery, and more efficient use of healthcare resources.
At MTIP, we believe that improving access to quality healthcare and generating sustainable value go hand in hand. We actively support our portfolio companies in expanding access to care, improving outcomes, and building resilient healthcare systems - while delivering strong financial performance. Sustainability is embedded in our investment approach. Therefore, MTIP Fund II is classified as Article 9 under SFDR, reflecting the highest standard for sustainable investing.
We measure impact through our proprietary MTIP Impact Tracker, based on the AAAQ framework (Availability, Accessibility, Acceptability and Quality), assessing how our investments improve access to healthcare. As a Certified B Corporation and a PRI signatory, we operate in line with leading global standards for responsible investment. Further information is available in our sustainability and impact reports.
MTIP’s ESG Policy outlines the requirements and process to ensure a sustainable investment approach.
Our investment objectives, guidelines, criteria and processes are based on various internationally acknowledged frameworks. Our ESG approach is based on two pillars in which we link measurable positive impacts with adequate ESG risk management.
This policy outlines the requirements of MTIP to ensure an inclusive culture.
MTIP is an equal opportunity employer and the working culture at MTIP is marked by tolerance and mutual respect. We strive to provide an inclusive environment where everyone feels welcomed and comfortable.
MTIP's remuneration policy ensures that the company maintains and applies a sound and prudent remuneration process which does not impair compliance with the company’s duty to act in the best interests of its clients, which identifies and manages any conflicts of interest, encourages sound and effective risk management and does not encourage risk taking which is inconsistent with the risk profile of the company.
In line with MTIP’s Remuneration Policy, all Identified Staff and Investment Professionals are compensated based on a fixed and variable component. The balance between the fixed and performance-based components of the remuneration shall be reasonable to promote long-term value creation and avoid seeking short-term risks to gain personal advantage.
.svg)
.svg)
